In-process evaluation of culture errors using morphology-based image analysis

Introduction Advancing industrial-scale manufacture of cells as therapeutic products is an example of the wide applications of regenerative medicine. However, one bottleneck in establishing stable and efficient cell manufacture is quality control. Owing to the lack of effective in-process measurement technology, analyzing the time-consuming and complex cell culture process that essentially determines cellular quality is difficult and only performed by manual microscopic observation. Our group has been applying advanced image-processing and machine-learning modeling techniques to construct prediction models that support quality evaluations during cell culture. In this study, as a model of errors during the cell culture process, intentional errors were compared to the standard culture and analyzed based only on the time-course morphological information of the cells. Methods Twenty-one lots of human mesenchymal stem cells (MSCs), including both bone-marrow-derived MSCs and adipose-derived MSCs, were cultured under 5 conditions (one standard and 4 types of intentional errors, such as clear failure of handlings and machinery malfunctions). Using time-course microscopic images, cell morphological profiles were quantitatively measured and utilized for visualization and prediction modeling. For visualization, modified principal component analysis (PCA) was used. For prediction modeling, linear regression analysis and the MT method were applied. Results By modified PCA visualization, the differences in cellular lots and culture conditions were illustrated as traits on a morphological transition line plot and found to be effective descriptors for discriminating the deviated samples in a real-time manner. In prediction modeling, both the cell growth rate and error condition discrimination showed high accuracy (>80%), which required only 2 days of culture. Moreover, we demonstrated the applicability of different concepts of machine learning using the MT method, which is effective for manufacture processes that mostly collect standard data but not a large amount of failure data. Conclusions Morphological information that can be quantitatively acquired during cell culture has great potential as an in-process measurement tool for quality control in cell manufacturing processes.

[1]  Siu Kang,et al.  Non-invasive quality evaluation of confluent cells by image-based orientation heterogeneity analysis. , 2016, Journal of bioscience and bioengineering.

[2]  P. Moghe,et al.  A high content imaging-based approach for classifying cellular phenotypes. , 2013, Methods in molecular biology.

[3]  Ross A. Marklein,et al.  High Content Imaging of Early Morphological Signatures Predicts Long Term Mineralization Capacity of Human Mesenchymal Stem Cells upon Osteogenic Induction , 2016, Stem cells.

[4]  Z. Han,et al.  Safety of Mesenchymal Stem Cells for Clinical Application , 2012, Stem cells international.

[5]  Hiroto Sasaki,et al.  Label-Free Morphology-Based Prediction of Multiple Differentiation Potentials of Human Mesenchymal Stem Cells for Early Evaluation of Intact Cells , 2014, PloS one.

[6]  A. Bakopoulou,et al.  Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects “stemness” properties , 2017, Stem Cell Research & Therapy.

[7]  Dieter Eibl,et al.  Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges , 2018, Applied Microbiology and Biotechnology.

[8]  Kirsten Parratt,et al.  Cells as advanced therapeutics: State‐of‐the‐art, challenges, and opportunities in large scale biomanufacturing of high‐quality cells for adoptive immunotherapies , 2017, Advanced drug delivery reviews.

[9]  Maximilian Kerz,et al.  A Novel Automated High-Content Analysis Workflow Capturing Cell Population Dynamics from Induced Pluripotent Stem Cell Live Imaging Data , 2016, Journal of biomolecular screening.

[10]  Hiroyuki Honda,et al.  Characterization of Time-Course Morphological Features for Efficient Prediction of Osteogenic Potential in Human Mesenchymal Stem Cells , 2014, Biotechnology and bioengineering.

[11]  Hiroto Sasaki,et al.  Comparisons of cell culture medium using distribution of morphological features in microdevice. , 2016, Journal of bioscience and bioengineering.

[12]  Glyn Stacey,et al.  Soliciting Strategies for Developing Cell-Based Reference Materials to Advance Mesenchymal Stromal Cell Research and Clinical Translation , 2014 .

[13]  Albert A. Rizvanov,et al.  Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment , 2018, Front. Pharmacol..

[14]  Giuseppe Remuzzi,et al.  Mesenchymal stromal cells for tolerance induction in organ transplantation. , 2017, Human immunology.

[15]  Veronica Mariotti,et al.  Mesenchymal stromal/stem cells in drug therapy: New perspective. , 2017, Cytotherapy.

[16]  Carl A. Gregory,et al.  Mechanisms of mesenchymal stem/stromal cell function , 2016, Stem Cell Research & Therapy.

[17]  Hiroyuki Honda,et al.  Morphology-Based Prediction of Osteogenic Differentiation Potential of Human Mesenchymal Stem Cells , 2013, PloS one.

[18]  Mahnaz Maddah,et al.  A System for Automated, Noninvasive, Morphology-Based Evaluation of Induced Pluripotent Stem Cell Cultures , 2014, Journal of laboratory automation.

[19]  ViswanathanSowmya,et al.  Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation. , 2014 .

[20]  Ryuji Kato,et al.  Image-based focused counting of dividing cells for non-invasive monitoring of regenerative medicine products. , 2015, Journal of bioscience and bioengineering.

[21]  S. Oja,et al.  Automated image analysis detects aging in clinical-grade mesenchymal stromal cell cultures , 2018, Stem Cell Research & Therapy.

[22]  Abdolreza Esmaeilzadeh,et al.  Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer , 2017, Front. Immunol..

[23]  Bruce R. Conklin,et al.  A Non-invasive Platform for Functional Characterization of Stem-Cell-Derived Cardiomyocytes with Applications in Cardiotoxicity Testing , 2015, Stem cell reports.

[24]  C. De Bari,et al.  Stem cell‐based therapeutic strategies for cartilage defects and osteoarthritis , 2018, Current opinion in pharmacology.

[25]  Bryan A. Millis,et al.  Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells. , 2013, Cytotherapy.